Displaying One Session

View
Room A Wed, 08.12.2021 16:30 - 18:00

Optimising I-O drug clinical development (ID 3)

Date
Wed, 08.12.2021
Time
16:30 - 18:00
Location
Room A
Chairs
  • Samra Turajlic (London, GB)
Optimising I-O drug clinical development (ID 3) Educational session

What can we learn from negative trials in immunotherapy? (ID 16)

Lecture Time
16:30 - 16:50
Speakers
  • Alexander M. Eggermont (Utrecht, NL)
Session Name
Optimising I-O drug clinical development (ID 3)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Authors
  • Alexander M. Eggermont (Utrecht, NL)
Optimising I-O drug clinical development (ID 3) Educational session

Anti-tumour immunity at different stages of tumour evolution/progression (ID 17)

Lecture Time
16:50 - 17:10
Session Name
Optimising I-O drug clinical development (ID 3)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Optimising I-O drug clinical development (ID 3) Educational session

What biomarkers should we be using to give us better positive outcomes (ID 18)

Lecture Time
17:10 - 17:30
Speakers
  • Samra Turajlic (London, GB)
Session Name
Optimising I-O drug clinical development (ID 3)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Authors
  • Samra Turajlic (London, GB)
Optimising I-O drug clinical development (ID 3) Educational session

Circulating biomarkers of response to immunotherapy (ID 19)

Lecture Time
17:30 - 17:50
Speakers
  • Pablo Nenclares (London, GB)
Session Name
Optimising I-O drug clinical development (ID 3)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Authors
  • Pablo Nenclares (London, GB)
Optimising I-O drug clinical development (ID 3) Educational session

Q&A (ID 20)

Lecture Time
17:50 - 18:00
Session Name
Optimising I-O drug clinical development (ID 3)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00